Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure
Gynecologic and Obstetric Investigation · 2025
DOI: 10.1159/000546442 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Linda B P M Stevens Brentjens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands, linda.brentjens@mumc.nl. Hauptthemen laut MEDLINE: Endometrium, Estradiol, Embryo Implantation, 17-Hydroxysteroid Dehydrogenases. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Alterations in 17β-estradiol metabolism are known to potentially impair endometrial receptivity. Previous pioneering studies have investigated the role of endometrial steroid metabolism by determining steroid hormone levels and steroid-metabolizing enzyme activity in endometrial biopsies of patients undergoing IVF. The activity of oxidative and reductive 17β-hydroxysteroid dehydrogenases (17β-HSDs), which catalyse the interconversion between estrone and 17β-estradiol, was found to be similar between IVF patients who - after fresh embryo transfer in the cycle following endometrial biopsy - did and did not become pregnant. However, inhibition of the reductive enzyme 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), the most prominent 17β-HSD type in 17β-estradiol formation, was found to differ between groups. The primary objective of this study is to determine oxidative and reductive 17β-HSD enzyme activity in the endometrium of two well-defined groups: IVF patients with Recurrent Implantation Failure (RIF) and control patients.
Design
Prospective observational study of IVF patients with RIF (n=52) and controls (n=25). Patients undergoing treatment because of pre-implantation genetic testing, a severe male factor or bilateral tubal pathology were recruited as controls, since these conditions did not suggest an endometrial contribution to infertility. Participants/Materials, Setting, Methods Endometrial biopsies were obtained 5 to 8 days after a positive urine ovulation test in a natural cycle using a Pipelle catheter. Activity of oxidative and reductive enzymes, inhibition of 17β-HSD1, 5, 7 and 12 and immunostaining of 17β-HSD7 were performed. The formation of 17β-estradiol by reduction of estrone (reductive enzymes), formation of estrone by oxidation of 17β-estradiol (oxidative enzymes) and inhibition of specific 17β-HSD enzymes was determined using high performance liquid chromatography. Formalin fixed paraffin embedded tissue was used for immunostaining. The Student’s t-test and Mann-Whitney U test were used for statistical analysis. Multivariate analysis was used to determine the influence of confounders.
Results
No differences were found in activity of oxidative and reductive 17β-HSD enzymes in RIF patients and controls. Combined inhibition of 17β-HSD5, 7 and 12 was significantly lower in the RIF group compared to controls (p=0.04). Inhibition of 17β-HSD1 and 17β-HSD7 combined was also significantly lower (more production of 17β-estradiol remained) in the RIF group compared to controls (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands, linda.brentjens@mumc.nl.
- GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands, linda.brentjens@mumc.nl.
- Department of Obstetrics and Gynaecology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
- GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
- Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Zitieren
APA
Stevens Brentjens, L. B. P. M., Delvoux, B., den Hartog, J. E., Obukhova, D., Xanthoulea, S., Romano, A., & van Golde, R. J. T. (2025). Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000546442
Vancouver
Stevens Brentjens LBPM, Delvoux B, den Hartog JE, Obukhova D, Xanthoulea S, Romano A, et al. Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000546442
BibTeX
@article{StevensBrentjens2025,
author = {Stevens Brentjens, Linda B P M and Delvoux, Bert and den Hartog, Janneke E and Obukhova, Darina and Xanthoulea, Sofia and Romano, Andrea and van Golde, Ron J T},
title = {Endometrial metabolism of 17β-estradiol during the window of implantation in women with recurrent implantation failure},
journal = {Gynecologic and Obstetric Investigation},
year = {2025},
doi = {10.1159/000546442}
}
EUVIMED